Overview

A Study of Caldolor in Hospitalized Febrile Pediatric Patients

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study of Caldolor administered to febrile hospitalized pediatric patients every 6 hours for 24 hours is to determine the clinical equivalence of a single dose of Caldolor compared to acetaminophen (paracetamol; APAP) for the treatment of fever as measured by the AUC Tº within the first 6 hours of treatment (as compared to a target temperature of 98.6ºF [37.0ºC]).
Phase:
Phase 3
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Ibuprofen